Literature DB >> 8976073

[Diagnosis of pleural dissemination lung cancer by thin-section CT--a prospective study].

K Mori1, T Hirose, S Machida, K Yokoyama, M Sawafuji, K Yokoi, K Tominaga.   

Abstract

In this prospective study, thin-section CT was used to diagnose pleural dissemination in patients with pulmonary adenocarcinomas in which the primary lesion was found to be adjacent to the pleural surface by conventional CT. The subjects were 32 patients (25) who had undergone resection and 7 who had not with pulmonary adenocarcinoma without pleural effusion from among the 136 patients with pulmonary adenocarcinoma examined at our institution over 3 years. Thin-section CT images of three regions were obtained, and these included the pleural surface adjacent to the lesion, the minor fissure, and the diaphragmatic dome. Histopathological examination revealed pleural dissemination in 12 patients (5 who had undergone resection and who had not), in 2 of whom a diagnosis could not be made preoperatively. Pleural dissemination was diagnosed by CT in 12 patients; there were 2 false positives. In 6 patients who did not undergo resection, cancerous cells were found in fluid obtained by percutaneous pleural lavage, and mediastinal lymph node metastases or distant metastases were also detected. The diagnostic rate of CT was as follows interlobar space. 100% (7/7); mediastinum, 75% (3/4); diaphragm, 71% (5/7); and chest wall, 57% (4/7). In the patients who underwent resection, sensitivity was 100% for the interlobar space, but it was 0% to 33% for other pleural surfaces.

Entities:  

Mesh:

Year:  1996        PMID: 8976073

Source DB:  PubMed          Journal:  Nihon Kyobu Shikkan Gakkai Zasshi        ISSN: 0301-1542


  1 in total

1.  Diaphragmatic hernia during treatment of lung cancer harboring an EGFR mutation.

Authors:  Aya Konno-Yamamoto; Osamu Narumoto; Shota Yamamoto; Miho Yamaguchi; Makoto Motoyoshi; Yuta Inoue; Takeshi Fukami; Atsuhisa Tamura; Hirotoshi Matsui
Journal:  Oxf Med Case Reports       Date:  2021-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.